Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 414 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Active Transcranial Direct Current Stimulation Clear all

Conditions: Fall, Gait, Unsteady, Mobility Limitation
Interventions: Transcranial direct current stimulation (tDCS) (active), Transcranial direct current stimulation (tDCS) (Sham); Device
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 65 Years and older
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Dyslexia, Reading Disability
Interventions: Active transcranial electrical stimulation (tES), Sham transcranial electrical stimulation (tES); Device
Lead sponsor: General Neuro Inc.; Industry
Eligibility: 7 Years to 17 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Smoking, Cigarette, Craving, Addiction, Nicotine
Interventions: Real cTBS, Sham cTBS, Real iTBS, Sham iTBS; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 70 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Post-Concussion Syndrome
Interventions: Transcranial Direct Current Stimulation; Device
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 30 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Spinal Cord Injury, Chronic Pain, Neuropathic Pain
Interventions: Transcranial direct current stimulation (tDCS); Device
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity
Interventions: Active transcranial direct current stimulation (tDCS), Hypocaloric diet, Sham transcranial direct current stimulation (tDCS); Device · Other
Lead sponsor: University of Sao Paulo; Other
Eligibility: 20 Years to 40 Years · Female only
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Major Depressive Disorder
Interventions: tDCS intervention applied by Starstim device; Device
Lead sponsor: Neuroelectrics Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 4
States / cities: Coral Springs, Florida • Miami, Florida • Snellville, Georgia + 1 more

Conditions: Trigeminal Neuropathic Pain
Interventions: PET Scans, transcranial direct current stimulation (tDCS), MRI, sham tDCS (prior to real tDCS); Procedure · Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Anorexia Nervosa, Bulimia Nervosa
Interventions: Transcranial magnetic stimulation, Transcranial direct current stimulation; Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Stroke
Interventions: tDCS: noninvasive brain stimulation, Constraint induced movement therapy (CIMT), Sham tDCS: placebo noninvasive brain stimulation; Procedure · Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 21 Years and older
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Alzheimer&Amp;#39;s Disease, Other Dementias
Interventions: Active tDCS paired with active online chair yoga; Device
Lead sponsor: University of Arizona; Other
Eligibility: 60 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Cocaine Use Disorder, Cocaine Dependence
Interventions: transcranial direct current stimulator (tDCS), Cognitive Reappraisal; Device · Behavioral
Lead sponsor: Soterix Medical; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Parkinson's Disease, Tourette's Syndrome, Tic Disorders, Dystonia, Movement Disorders
Interventions: Transcranial Direct Current Stimulation (tDCS), Eye-tracking Device, Pulsed vibrator, Gait Trainer Treadmill (GTT), Standard psychiatric scales SCID-I, YBOCS and SCI-OBS-lifetime and cognitive scales MMSE and MOCA, iMobility, QMAT, Treadmill Test, Arm Intellistretch Device, Transcranial Sonography (TCS), Behavioral tasks, TMS single/paired pulse, MEG, EEG, MRI techniques, Peripheral Nerve Stimulation, EMG, Trancutaneous spinal direct current stimulation (tsDCS); Procedure · Device · Other + 1 more
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years and older
Enrollment: 1,273 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mild Cognitive Impairment, Alzheimer's Disease
Interventions: Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unit; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years to 88 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Healthy
Interventions: HD-tDCS; Device
Lead sponsor: Brooklyn College of the City University of New York; Other
Eligibility: 18 Years to 35 Years
Enrollment: 216 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Alzheimer Disease
Interventions: transcranial alternating current stimulation (tACS); Device
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 21 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Brain Concussion, Brain Trauma, Attention Concentration Difficulty, Brain Injuries, Brain Injuries, Traumatic, Neurocognitive Dysfunction, Attention Impaired, Memory Impairment, Mild Traumatic Brain Injury, Mild Cognitive Impairment
Interventions: active tDCS and cognitive training intervention, sham tDCS and cognitive training intervention; Combination Product
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Headaches Posttraumatic, Neck Pain
Interventions: Exercise, transcranial direct current stimulation; Behavioral · Device
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: Temporomandibular Disorder
Interventions: HD-tDCS*, Sham HD-tDCS*; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Alzheimer&Amp;#39;s Disease-related Dementia, Alzheimer Disease, rTMS Stimulation
Interventions: Brain Stimulation; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 65 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Complex Regional Pain Syndrome (CRPS)
Interventions: transcranial alternating current stimulation (tACS); Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hemorrhagic Stroke, Hemiparesis
Interventions: dual transcranial direct current stimulation; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Depression
Interventions: Transcranial Electrical Stimulation (tES); Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Migraine
Interventions: HD-tDCS Active Protocol, HD-tDCS Sham Protocol; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Search by objective public record fields.

Non-invasive Brain Stimulation to Improve Unsteady Gait in Older Adults (StimGait)

Brain Stimulation Paired With Structured Reading Instruction in Children With Dyslexia

QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt

Cerebellar TDCS for SRPCS Treatment

Spaulding-Harvard Model System: Effects of Transcranial Direct Current Stimulation (tDCS) on Chronic Pain in Spinal Cord Injury

Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity

Home-based Transcranial Direct Current Stimulation (tDCS) for Major Depressive Disorders (MDD)

Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain

Transcranial Treatments in Eating Disorders

Brain Stimulation-aided Stroke Rehabilitation: Neural Mechanisms of Recovery

Remote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's Patients

TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study

Physiological Investigations of Movement Disorders

Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment

Effects of Brain-stimulation on Metamemory Monitoring and Control

Memory Functions in Mild Alzheimer's Disease

tDCS and Cognitive Training in Active Duty Service Members With Mild TBI: A Pilot Study

Feasibility of Exercise and Transcranial Direct Current Stimulation for the Treatment of Post-traumatic Headache

Investigation and Modulation of the Mu-opioid Mechanisms in TMD (in Vivo)

Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease

Effects of Non-invasive Brain Stimulation on Pain Avoidance Behavior in Chronic Pain Patients

Dual Transcranial Direct Current Stimulation (dTDCS)-Enhanced Therapy After Hemorrhagic Strokes and VEGF

fMRI Study of tES in Major Depression

Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)